ENGN · Insider trading · 13F holders · Congress trades
enGene Therapeutics Inc. (ENGN)
Who is buying and selling ENGN: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 9
- Insider buys, 90 days
- $10K
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
ENGN at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 ENGN insider filed 1 open-market purchase worth $10K on SEC Form 4.
- 9 13F filers hold ENGN among their 50 largest positions, worth $40.5M combined. The biggest bets by portfolio weight are BML Capital Management, LLC (6.6%), Fcpm III Services B.v. (2.2%) and Peapod Lane Capital LLC (1.5%). In their latest 13Fs, 5 managers opened a new position and 0 added to one.
- No member of Congress has disclosed a trade in ENGN.
- ENGN last closed at $1.53 on Oct 29, 2026.
ENGN insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 ENGN insider filed 1 open-market purchase worth $10K on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Grossman William | Interim Chief Medical Officer, Director | Buy | 5,102 | $1.97 | $10K | SEC |
Who owns ENGN? Hedge funds and superinvestors
9 13F filers hold ENGN among their 50 largest positions, worth $40.5M combined. The biggest bets by portfolio weight are BML Capital Management, LLC (6.6%), Fcpm III Services B.v. (2.2%) and Peapod Lane Capital LLC (1.5%). In their latest 13Fs, 5 managers opened a new position and 0 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Fcpm III Services B.v.Hedge fund | 2.2% | $16.7M | 9,632,561 | +0.0% shares | Q2 2026 |
| BML Capital Management, LLCHedge fund | 6.6% | $11.5M | 6,669,908 | New | Q2 2026 |
| Nextech Invest Ltd.Hedge fund | 0.2% | $4.0M | 2,324,943 | New | Q2 2026 |
| Acorn Capital Advisors, LLCHedge fund | 0.6% | $2.2M | 1,271,257 | New | Q2 2026 |
| Peapod Lane Capital LLCInstitutional asset manager | 1.5% | $2.1M | 1,038,617 | -5.8% shares | Q3 2026 |
| Omega Fund Management, LLCHedge fund | 0.8% | $1.5M | 876,357 | +0.0% shares | Q2 2026 |
| SR One Capital Management, LPHedge fund | 0.1% | $1.3M | 747,750 | +0.0% shares | Q2 2026 |
| Kynam Capital Management, LPHedge fund | 0.0% | $792K | 457,855 | New | Q2 2026 |
| Elmind Capital, LPHedge fund | 0.1% | $363K | 210,000 | New | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 8). Screen ENGN in the grand portfolio →
ENGN stock trades by members of Congress
No member of Congress has disclosed a trade in ENGN.
ENGN questions and answers
Are insiders buying ENGN stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 ENGN insider filed 1 open-market purchase worth $10K on SEC Form 4.
Which hedge funds own ENGN?
9 13F filers hold ENGN among their 50 largest positions, worth $40.5M combined. The biggest bets by portfolio weight are BML Capital Management, LLC (6.6%), Fcpm III Services B.v. (2.2%) and Peapod Lane Capital LLC (1.5%). In their latest 13Fs, 5 managers opened a new position and 0 added to one.
Has Congress traded ENGN?
No member of Congress has disclosed a trade in ENGN.
Who is the largest holder of ENGN?
Among 13F filers, Fcpm III Services B.v. reports the largest ENGN position, $16.7M (9,632,561 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is BML Capital Management, LLC's: 6.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.